Piramal Pharma to acquire 100% stake in Hemmo Pharma for Rs 775 crore Piramal Pharma Solutions (PPS) made this third acquisition of FY21 as it entered into an agreement to purchase a 100% stake in Hemmo Pharmaceuticals Pvt. Ltd for ₹775 crore. PPS is the contract development and manufacturing organization (CDMO) of Piramal Pharma Ltd (PPL). The acquisition marks PPS’ foray into the development and manufacturing of peptide APIs (active pharmaceutical ingredients), complementing its existing service offerings.
This is your website preview.
Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.
Piramal Pharma to acquire 100% stake in Hemmo P...
2021-04-23T12:26:28
Piramal Pharma to acquire 100% stake in Hemmo Pharma for Rs 775 crore Piramal Pharma Solutions (PPS) made this third acquisition of FY21 as it entered into an agreement to purchase a 100% stake in Hemmo Pharmaceuticals Pvt. Ltd for ₹775 crore. PPS is the contract development and manufacturing organization (CDMO) of Piramal Pharma Ltd (PPL). The acquisition marks PPS’ foray into the development and manufacturing of peptide APIs (active pharmaceutical ingredients), complementing its existing service offerings.
2021-04-23T12:26:28
Share it on
Submit Your Enquiry